A Second Medical Nemesis

From Pauling’s orthomolecular hypothesis through Ames’s triage theory to the podcast economy that carried the intuition and depoliticised it. Ivan Illich’s frame extended to the expropriation of the physiological substrate, and the return of that substrate to the person it belongs to.

In 1975 Ivan Illich published Medical Nemesis. The book named three iatrogeneses. Clinical, the direct damage of treatment: the side effect, the surgical error, the hospital infection. Social, the medicalisation of ordinary experience: birth, pain, aging, dying converted into objects of professional management. Cultural, the erosion of the human capacity to cope with one’s own condition. Nemesis, in the Greek register Illich chose, is retribution against hubris. The hubris punished in the book is the monopoly the medical profession had assumed over the entire field of health.

The word Illich used across the argument is expropriation. The profession did not merely fail its patients. It took from them something they had held before its arrival, and returned it in a form only the profession could interpret. Health, formerly a capacity, became a service. Fifty years of readers have tended to receive the book as a critique of hospital medicine, of the physician’s arrogance, of the pharmaceutical machine. All of this is in the book. What is less often noticed is that Illich’s frame accommodates chapters he did not write, because his epoch could not yet write them.

One of those chapters is the expropriation of the physiological substrate.

The Pauling opening

In 1968 Linus Pauling published, in Science, a paper titled “Orthomolecular Psychiatry”. The proposition was that mental illness could in part be understood as a departure from optimal concentrations of substances normally present in the body. The word he chose, orthomolecular, means the correct molecule at the correct concentration. It is a claim about substrate. It says: the mind rides on a biochemistry, that biochemistry has a functional target, and departures from the target produce mental effects that are visible in the clinic.

Pauling was a Nobel laureate twice over. His paper was not received well. The psychiatric profession dismissed the argument as the eccentricity of an aging chemist. A generation of nutritional psychiatry was thereby foreclosed at the institutional level. Pauling continued, wrote about vitamin C and cancer, wrote about heart disease, was met with derision. When he died in 1994, the orthomolecular argument sat outside the mainstream, though it had never been refuted at the level of its central intuition.

The intuition was that optimal concentrations exist, that they differ from statistical averages, and that the difference matters clinically. Everything the physiological rights argument develops today rests on that intuition. Pauling stated it first, and he stated it publicly, and he paid the professional price.

The Ames continuation

The intuition did not die. It was carried forward inside the institution by a researcher with access to the apparatus Pauling was denied. Bruce Ames, biochemist at Berkeley, member of the National Academy of Sciences, developer of the Ames test for mutagenicity, published in PNAS in 2006 a paper titled “Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage”. He named the argument the triage theory.

The triage theory reads: under marginal deficiency of a required cofactor, the body allocates the limited supply to functions with immediate survival value, and starves functions whose failure produces harm only over decades. The DNA repair machinery is starved. The mitochondrial membrane is compromised over years. The immune response degrades slowly. The body triages exactly as any resource-constrained system triages, and it does so silently, without producing the acute symptoms the deficiency textbook would recognise. The person walks around apparently well. The damage accumulates. The disease of aging is the arrival, decades later, of the bill.

The triage theory is Pauling’s insight in scientific dress. The vocabulary is not the same. The target audience is not the same. But the claim is: optimal concentrations exist, functional targets differ from statistical ranges, and the gap between statistical adequacy and functional adequacy is where a very large fraction of chronic disease is silently generated. Ames published this in PNAS, the journal of the Academy. The claim entered, on paper, the institutional record at the highest tier the discipline offers.

It did not enter the clinic.

Ames was Pauling’s worthy successor in the register that mattered: the register of institutional legitimacy for an unpopular thesis. He carried the argument across four decades from Science 1968 to PNAS 2006 without breaking with the discipline that had rejected its founder. The rejection persisted at the level of clinical translation, but the citation record was now on the correct side of the argument. The intuition had crossed the wall of the Academy. It had not crossed the wall of the practice.

The vehicle changes

Rhonda Patrick did her postdoctoral work in Ames’s laboratory at CHORI. She left the laboratory. She built a podcast. She named it FoundMyFitness. The Pauling-Ames intuition rides along in her voice, in the questions she asks her guests, in the emphasis she places on micronutrient sufficiency, on omega-3 index, on vitamin D, on the marginal-deficiency framework. She carried the intuition to millions of listeners the PNAS paper never reached. This is, in the flat descriptive sense, a form of continuity.

But the vehicle changed what the intuition could do. In Ames’s laboratory, the intuition addressed the discipline. It asked the discipline to reconsider its reference ranges, its trial designs, its framing of aging. In Patrick’s podcast, the intuition addresses the consumer. It asks the consumer to reconsider his supplement stack, his blood panel, his sleep. The two audiences are separated by a wall that has nothing to do with content and everything to do with jurisdiction. The physician, hearing the intuition on a podcast, receives it as a lay concern. The intuition is thereby returned to the discipline in a form the discipline cannot receive.

The economy that built the podcast is not neutral in this transfer. The sponsors are supplement companies, testing companies, wearable companies, longevity clinics. The listener is a customer. The customer’s health becomes, at every episode, a market for the objects the sponsors sell. The frame is not the frame of a public health argument. It is the frame of a curated purchasing pathway. The wall between listener and physician thickens, and the physician’s rejection of the argument as commercially contaminated becomes, in the discipline’s own terms, defensible.

Illich called the second iatrogenesis social: the medicalisation of the ordinary. The podcast economy has produced a mirror-image iatrogenesis. The commodification of the ordinary. Both expropriate. The one by professional monopoly, the other by consumer capture. The person whose substrate is at stake is the same person in both cases.

The Huberman revelation

Andrew Huberman built the largest scientific podcast on the internet by explaining, in careful and often overlong detail, the mechanisms by which the human body works. The success of the format is not a personal achievement. It is a datum. A population of tens of millions of adults, mostly outside medicine, listens for hours a week to a Stanford neurobiologist explaining glucose metabolism, dopamine circuits, cold exposure, sleep architecture. The population is showing up. It wants the explanation. Nothing in the mainstream medical delivery system is offering it.

This is the piece Huberman contributes to the argument regardless of what one thinks of his specific claims. He proves an appetite. The appetite is for the physiological register. Ordinary adults will read Bredesen, will run their own homocysteine, will pay for a Cyrex panel, will listen to two hours on the mechanism of the ATP synthase, because they want to inhabit a body they understand. The desire is dignified. It is what a rights-based medicine would recognise as an expression of the very interest the discipline has expropriated.

That the appetite is currently monetised by ring lights and supplement sponsors does not disqualify the appetite. It disqualifies the delivery. The person who wants to understand her own physiology is not a mark. She is a rights-holder without a legitimate channel. She goes to the illegitimate one because the legitimate one has been closed.

The panorama

Around Patrick and Huberman a broader scene has assembled. Peter Attia performs longevity medicine as an elite service, with a book, a clinic, a subscription. Thomas DeLauer sells low-carb pedagogy to men who want to see abdominal muscles. Adjacent figures occupy every angle between them. Each serves a slice of the appetite Huberman revealed. Each monetises that slice through some blend of subscription, sponsorship, and product. Each, whatever the intellectual quality of the specific contribution, participates in an economy whose selection pressure runs against the political conclusion the material actually implies.

Selection pressure runs against politicisation because politicisation costs sponsors. The moment a metabolic educator suggests that food policy is a matter for the FDA and the USDA to redesign, half of his supplement sponsors reconsider their contracts. The moment a longevity clinician argues that his services should be nationalised and delivered to any citizen who needs them, his private-clinic business model collapses. The economy of the alternative-health podcast rewards a specific range of moves. Empowerment of the individual customer. Distrust of institutions in general terms. Silence on the structural implications of the biology.

The result is a curated body of knowledge that ends, in every episode, at the checkout page. The listener leaves better informed about her thyroid than her GP will make her. She also leaves oriented toward a private-transaction fix for what she has learned. That the fix works, on the individual level, for those who can pay, is not disputed. What is disputed is that this represents the mature form of the Pauling-Ames intuition. It is not. It is the intuition’s monetised residue.

The line that stayed political

There is a parallel line that refused the arrangement. Robert Lustig has been publishing on sugar and metabolic disease for twenty-five years, has taken the argument to congressional testimony, to public regulation, to sugar taxes. Aseem Malhotra has campaigned against statin overprescription and industry capture of cardiology guidelines with a persistence that has cost him professional standing. Marion Nestle has spent forty years documenting how the food industry writes the science, the guidelines, the school lunch. These are not the largest audiences in the scene. They are the figures who chose regulation over subscription, and testimony over the affiliate link.

They matter because they show that the depoliticisation of the alternative-health economy is a choice, not a necessity of the terrain. The material lends itself to politicisation. Sugar policy is a policy question. Statin overuse is a policy question. Food industry capture is a policy question. The reason most figures in the scene do not treat their material this way is that the market they have entered rewards a different treatment.

An account that mentions only the depoliticised line risks confirming, by omission, that the biology has no political content. It does. The political line exists. It is not the loudest line, but it is there, and it is honourable, and it is the line the physiological rights argument extends.

Norwitz and the honest individualist

Nick Norwitz occupies a specific position in the scene. He is a Harvard-trained physician-scientist, publishes case reports on his own metabolism, is intellectually careful in a way many of his contemporaries are not. His signature move is the n=1 experiment on himself, carried through with instrumentation, documented, published. He does not claim generalisability. He claims that a person, careful enough and instrumented enough, can recover something the population trial has hidden from him.

That claim is not trivial. Taken to its logical end, it is a critique of the entire epistemic architecture of population medicine. If each person is metabolically singular enough that his own case report is informative in a way the RCT is not, then the RCT’s monopoly on clinical truth has been silently dismantled from within. Norwitz does not shout this conclusion. He enacts it. Every video is another instance of the same claim: I measured myself, at this resolution, and I found what the population study would have averaged away.

The physiological rights argument shares this ground. The person is metabolically singular. Her substrate has to be measured at her resolution, corrected against her functional target, not against the population’s statistical range. Norwitz is doing, on himself, what a rights-based medicine would require the system to do for anyone who asks.

The problem is that Norwitz’s version stays inside a private economy. His n=1 is financed by an academic salary or a Substack. The mother in Delhi cannot run his stack. The teacher in Kinshasa cannot buy his continuous glucose monitor. If the n=1 is the standard of care that a serious physiological understanding of the body requires, then the n=1 has to be delivered as a right, or it becomes a boutique service for the well-financed. Norwitz’s individualism is intellectually honest. It is also structurally incomplete.

The completion is jurisdictional. The intuition Pauling opened, Ames rescued, Patrick popularised, Huberman scaled, and Norwitz individualised, has one further transformation to undergo before it becomes usable at the level of the mother in Delhi. It has to become a right.

The second nemesis

Illich’s Nemesis was the retribution the medical profession earned by expropriating health. The retribution took the form of a public that could no longer manage its own condition, and a profession whose iatrogenic footprint had begun to rival the diseases it was treating. The book was received as a critique of hospital medicine. It was that. It was also a general theory of what happens to a competence when a monopoly assumes it.

The second nemesis is what happens to the same competence when a market assumes it. The physiological substrate, expropriated from the person by the profession, is not returned to the person by the podcast. It is transferred, in a new form, to another commercial architecture. The person, in both arrangements, remains a passive recipient of an interpretation someone else is authorised to produce. The professional interpretation was clothed in the white coat. The podcast interpretation is clothed in the ring light. Both are, in Illich’s structural sense, expropriations.

The escape from the second nemesis is not another podcast. It is the recognition that the physiological substrate is not a commodity, and not a specialist domain, and not a subscription tier. It is the substance of the body of the person. The person has a claim on it. That claim, when articulated at the level of the international instruments already ratified by the states in which the persons live, is a right.

Pauling opened the register. Ames legitimised the register inside the discipline. The podcast economy carried the register to a scale the discipline had refused. The register does not belong on a podcast. It belongs in a courtroom, in a constitution, in a general comment, in a structural order compelling a health system to measure and correct what a body needs.

The chapter Illich did not write, because his epoch could not yet write it, ends there.